Sequence Bio
sequencebio.comDiscovering the true signals of disease to power life-changing medicines
Health & Wellnessbiotechnologygenomicsmulti-omicsdrug-discoverypopulation-geneticsrare-diseasebioinformatics
About
Sequence Bio is a data-driven biotechnology company based in Newfoundland and Labrador, Canada. It leverages the unique genetic characteristics of the region's founder population, combined with multi-omics data and real-world patient records, to accelerate disease target discovery. The company aims to enable the development of better medicines faster by identifying low-frequency, high-impact genetic variants linked to disease.
Problem
Identifying meaningful genetic signals for disease is hampered by biological variation and incomplete patient data in most populations.
For
Pharmaceutical and biotech companies seeking novel drug targets
How it works
Sequence Bio uses the founder population of Newfoundland and Labrador — which has less genetic variation — combined with complete health records and multi-omics data to efficiently discover high-impact disease variants.
Business model
unknown
Status
launched
Company
Sequence Bio